Literature DB >> 17928346

Viral and host factors in human respiratory syncytial virus pathogenesis.

Peter L Collins1, Barney S Graham.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17928346      PMCID： PMC2258918          DOI： 10.1128/JVI.01625-07

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  162 in total

1.  Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Authors:  Bo Chi; Harold L Dickensheets; Kirsten M Spann; Marc A Alston; Cindy Luongo; Laure Dumoutier; Jiaying Huang; Jean-Christophe Renauld; Sergei V Kotenko; Mario Roederer; Judy A Beeler; Raymond P Donnelly; Peter L Collins; Ronald L Rabin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections.

Authors:  Simone Vallbracht; Heike Unsöld; Stephan Ehl
Journal:  Eur J Immunol       Date:  2006-06       Impact factor: 5.532

Review 3.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

4.  T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.

Authors:  Virginia Amanatidou; George Sourvinos; Stavros Apostolakis; Amalia Tsilimigaki; Demetrios A Spandidos
Journal:  Pediatr Infect Dis J       Date:  2006-05       Impact factor: 2.129

Review 5.  The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children.

Authors:  Mark L Everard
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-02

6.  Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells.

Authors:  Jörn-Hendrik Weitkamp; Bonnie J Lafleur; James E Crowe
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

7.  Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.

Authors:  Tom M A Wilkinson; Gavin C Donaldson; Sebastian L Johnston; Peter J M Openshaw; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

8.  Suppression of pattern-recognition receptor TLR4 sensing does not alter lung responses to pneumovirus infection.

Authors:  Pedro Faisca; Dao Bui Tran Anh; Anne Thomas; Daniel Desmecht
Journal:  Microbes Infect       Date:  2006-01-05       Impact factor: 2.700

9.  Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.

Authors:  Ann R Falsey; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Wayne M Sullender; Edward E Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

10.  The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.

Authors:  Alexander Bukreyev; Maria Elina Serra; Federico R Laham; Guillermina A Melendi; Steven R Kleeberger; Peter L Collins; Fernando P Polack
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103
View more
  236 in total

1.  Genetic immunization in the lung induces potent local and systemic immune responses.

Authors:  Kaimei Song; Diane L Bolton; Chih-Jen Wei; Robert L Wilson; Jeremy V Camp; Saran Bao; Joseph J Mattapallil; Leonore A Herzenberg; Leonard A Herzenberg; Charla A Andrews; Jerald C Sadoff; Jaap Goudsmit; Maria Grazia Pau; Robert A Seder; Pamela A Kozlowski; Gary J Nabel; Mario Roederer; Srinivas S Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

2.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

3.  A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate.

Authors:  M Chen; J S Chang; M Nason; D Rangel; J G Gall; B S Graham; J E Ledgerwood
Journal:  J Immunol Methods       Date:  2010-08-19       Impact factor: 2.303

Review 4.  Imaging viral RNA using multiply labeled tetravalent RNA imaging probes in live cells.

Authors:  Eric Alonas; Daryll Vanover; Emmeline Blanchard; Chiara Zurla; Philip J Santangelo
Journal:  Methods       Date:  2016-02-12       Impact factor: 3.608

5.  Inhibitory Effect of PIK-24 on Respiratory Syncytial Virus Entry by Blocking Phosphatidylinositol-3 Kinase Signaling.

Authors:  Li-Feng Chen; Wei-Bin Xu; Yue-Yue Li; Neng-Hua Chen; Ding Luo; Qiao-Yun Song; Wei Tang; Zhi-Gang Huang; Yao-Lan Li; Zhong Liu; Man-Mei Li
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

6.  Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus infected infants.

Authors:  Monica E Brint; Joshua M Hughes; Aditya Shah; Chelsea R Miller; Lisa G Harrison; Elizabeth A Meals; Jacqueline Blanch; Charlotte R Thompson; Stephania A Cormier; John P DeVincenzo
Journal:  Pediatr Res       Date:  2017-08-09       Impact factor: 3.756

7.  Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand.

Authors:  Junyan Han; Azzeddine Dakhama; Yi Jia; Meiqin Wang; Wanjiang Zeng; Katsuyuki Takeda; Yoshiki Shiraishi; Masakazu Okamoto; Steven F Ziegler; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

8.  Viral shedding and immune responses to respiratory syncytial virus infection in older adults.

Authors:  Edward E Walsh; Derick R Peterson; Aja E Kalkanoglu; Frances Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

9.  Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.

Authors:  Junyan Han; Katsuyuki Takeda; Meiqin Wang; Wanjiang Zeng; Yi Jia; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

Review 10.  A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.

Authors:  Boopathy Ramakrishnan; Karthik Viswanathan; Kannan Tharakaraman; Vlado Dančík; Rahul Raman; Gregory J Babcock; Zachary Shriver; Ram Sasisekharan
Journal:  Trends Microbiol       Date:  2016-10-14       Impact factor: 17.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.